Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alteplase in Acute Ischemic Stroke 3–4.5 Hours (China, Phase III)
CTR20160737Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of tissue-plasminogen activator in ischemic stroke, sponsored by Boehringer Ingelheim. Started Nov 2016; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20160737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160737.